Showing 161 - 170 of 358
Individual moral hazard engendered by health insurance and monopolistic production are both typical phenomena of drug markets. We develop a simple model containing these two elements and evaluate the market equilibrium on the basis of consumer and social welfare. The consumer welfare criterion...
Persistent link: https://www.econbiz.de/10010296968
Several authors have suggested that consumers purchase too much health insurance in private markets. We readdress this issue within a model that combines excess health-care demand due to health insurance with market power due to monopolistic production of health-care services. We evaluate the...
Persistent link: https://www.econbiz.de/10005143366
Individual moral hazard engendered by health insurance and monopolistic production are both typical phenomena of drug markets. We develop a simple model containing these two elements and evaluate the market equilibrium on the basis of consumer and social welfare. The consumer welfare criterion...
Persistent link: https://www.econbiz.de/10008509611
Individual moral hazard engendered by health insurance and monopolistic production are both typical phenomena of drug markets. We develop a simple model containing these two elements and show that private agents tend to overinsure themselves against health respectively drug expenses if drugs can...
Persistent link: https://www.econbiz.de/10010558549
Persistent link: https://www.econbiz.de/10001559480
By issuing tax-exempt bonds, the government can incur debt and never pay back any principal or interest, even if the economy without public debt evolves on a dynamically efficient growth path. The welfare effects of such a Ponzi type borrowing scheme are mixed. The current young will...
Persistent link: https://www.econbiz.de/10014401260
Persistent link: https://www.econbiz.de/10003057004
Persistent link: https://www.econbiz.de/10004444857
Persistent link: https://www.econbiz.de/10010117703
Persistent link: https://www.econbiz.de/10004850716